DR4 and DR5 dual agonist bi-specific Surrobody (i2 Pharmaceuticals)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameDR4 and DR5 dual agonist bi-specific Surrobody (i2 Pharmaceuticals)
Drug Alias Namedeath receptor 4/5 agonist (Sea Lane)dual cytokine receptor agonist (Sea Lane)SL-231
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionTumor necrosis factor receptor superfamily member 10A agonistsTumor necrosis factor receptor superfamily member 10B agonists
TargetsTumor necrosis factor receptor superfamily member 10BTumor necrosis factor receptor superfamily member 10A
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSea Lane Biotechnologies LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSea Lane Biotechnologies LLCi2 Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A